← Back to Search

Mechanical Circulatory Support Device

Intervention for Heart Failure

N/A
Waitlist Available
Led By William O.Neill, MD
Research Sponsored by Abiomed Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Study Summary

The use of Impella RP is safe, feasible and provides a hemodynamic benefit in patients with right ventricular failure.

Eligible Conditions
  • Heart Failure

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Primary Benefit Endpoint

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Abiomed Inc.Lead Sponsor
41 Previous Clinical Trials
34,525 Total Patients Enrolled
8 Trials studying Heart Failure
1,976 Patients Enrolled for Heart Failure
William O.Neill, MDPrincipal InvestigatorHenry Ford Hospital
Mark Anderson, MDPrincipal InvestigatorAlbert Einstein Medical Center
1 Previous Clinical Trials
1,017 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
The Journal of Heart and Lung TransplantationJournal
Benefits of a Novel Percutaneous Ventricular Assist Device for Right Heart Failure: The Prospective RECOVER RIGHT Study of the Impella RP Device
Anderson, Mark B., James Goldstein, Carmelo Milano, Lynn D. Morris, Robert L. Kormos, Jay Bhama, Navin K. Kapur, et al.. 2015. “Benefits of a Novel Percutaneous Ventricular Assist Device for Right Heart Failure: The Prospective RECOVER RIGHT Study of the Impella RP Device”. The Journal of Heart and Lung Transplantation. Elsevier BV. doi:10.1016/j.healun.2015.08.018.
clinicaltrials.govStudy
The Use of Impella RP Support System in Patients With Right Heart Failure
2013. "The Use of Impella RP Support System in Patients With Right Heart Failure". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01777607.
All > Heart Failure With Preserved Ejection Fraction
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top